US · Healthcare · Diagnostics & Research
EPS came in at 11.46 against a street estimate of 10.78 — a beat of 6.3%.
Analysts rate Mettler-Toledo International Inc a buy (4 buy, 9 hold, 0 sell out of 13) with an average price target of $1,414.36.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.76% |
| Vanguard Capital Management, LLC | 6.54% |
| Capital Research & Mgmt Co - Division 3 | 5.35% |
| Vanguard Portfolio Management, LLC | 4.93% |
| State Street Corp | 4.66% |
| AllianceBernstein L.P. | 3.75% |
| T. Rowe Price Investment Management,Inc. | 3.62% |
| Bank of New York Mellon Corp | 3.48% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-31 |
| Results announced · Q3 2026 | 2026-07-30 |
| Board / officer change · Q2 2026 | 2026-05-13 |
| Shareholder vote results · Q2 2026 | 2026-05-11 |
| Quarterly report · Q1 2026 | 2026-05-08 |
| Results announced · Q2 2026 | 2026-05-07 |
| Proxy statement · Q2 2026 | 2026-03-18 |
| Annual report FY2025 | 2026-02-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Mettler-Toledo International Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.